- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
6929
HKG
Week ended 07 Aug 2026
Weekly Investor Report
OrbusNeich Medical Group Holdings Limited · Healthcare · Medical Instruments & Supplies
Latest close
3.71 HKD
0.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 15.8% of its 52-week range. The latest completed week returned 0.3%, after a 1.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
26
out of 100
Latest Close
3.71 HKD
7 Aug 2026
1W Return
0.3%
latest completed week
4W Return
1.1%
short-term follow-through
12W Return
-10.3%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.3%
Latest completed week; four-week move 1.1%.
Indicator stack
22/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.13%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 15.8% of its 52-week range. The latest completed week returned 0.3%, after a 1.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2712-week average 0.34
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.1% over four weeks, -10.3% over 12 weeks, and -24.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change-2523.6%Four-week change in activity pressure.
Leadership-7.25Latest relative-leadership reading.
RS change-70.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-27.3%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+6.2%Week of 15 May.
Worst week-4.2%Week of 10 Jul.
Latest week+0.3%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks0
Modest losses12
Sharp losses2
Recent vol2.6%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank- / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Medical Instruments & Supplies
4-week rank5 / 11
Group average-2.1%
Trend breadth18.2%
Trend18.2%active weekly trend signals
MD27.3%positive activity pressure
RS18.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis47/100Latest 12-week confirmation: trend 5/12, activity pressure 7/12, relative leadership 7/12.
Activity pressure 0.27; No reversal markers Next-Week ExpectancyNegative 43.13%Next-week expectancy is negative with a 43.13% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
OrbusNeich Sets August Board Meeting to Review Interim Results and Dividend Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3.71 HKD | 0.3% | 3.81 HKD | 4.27 HKD | -0.72 | -7.25 | 366.0K | Off |
| 31 Jul 2026 | 3.70 HKD | -0.3% | 3.82 HKD | 4.30 HKD | -0.70 | -8.87 | 192.0K | Off |
| 24 Jul 2026 | 3.71 HKD | 0.5% | 3.82 HKD | 4.33 HKD | -0.52 | -5.95 | 87.0K | Off |
| 17 Jul 2026 | 3.69 HKD | 0.5% | 3.82 HKD | 4.35 HKD | -0.27 | -5.17 | 470.5K | Off |
| 10 Jul 2026 | 3.67 HKD | -4.2% | 3.81 HKD | 4.38 HKD | -0.03 | -4.26 | 780.5K | Off |
| 3 Jul 2026 | 3.83 HKD | -1.5% | 3.81 HKD | 4.41 HKD | 0.27 | 3.31 | 66.5K | On |
| 26 Jun 2026 | 3.89 HKD | -0.8% | 3.81 HKD | 4.43 HKD | 0.54 | 8.10 | 119.5K | On |
| 19 Jun 2026 | 3.92 HKD | -1.5% | 3.82 HKD | 4.46 HKD | 0.82 | 3.43 | 198.5K | On |
| 12 Jun 2026 | 3.98 HKD | -2.1% | 3.83 HKD | 4.49 HKD | 1.11 | 1.85 | 37.5K | On |
| 5 Jun 2026 | 4.07 HKD | -0.9% | 3.84 HKD | 4.52 HKD | 1.27 | 3.27 | 110.5K | On |
| 29 May 2026 | 4.11 HKD | -3.4% | 3.85 HKD | 4.55 HKD | 1.31 | 3.53 | 1.2M | Off |
| 22 May 2026 | 4.25 HKD | 2.8% | 3.86 HKD | 4.58 HKD | 1.04 | 5.52 | 2.5M | Off |
| 15 May 2026 | 4.14 HKD | 6.2% | 3.87 HKD | 4.62 HKD | 0.76 | 1.42 | 2.9M | Off |
| 8 May 2026 | 3.89 HKD | 5.5% | 3.88 HKD | 4.67 HKD | 0.56 | -5.98 | 781.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.